Professional Documents
Culture Documents
21 CFR 820 QSR - Training - 1
21 CFR 820 QSR - Training - 1
Training
PAST CURRENT
Research and
Operations Sales and Marketing
Development
QA/QC
Regulatory Research Lab
(Management Rep)
Design
User Needs Reviews
Design Inputs
Design
Process
Design
Verification
Outputs
Is it Done
Validation Right? Final Device
Does it Work?
February 03 Alquest – Linda Alexander
Quality System Element
Document Controls
z Establish and maintain a Quality System that is
appropriate for devices designed and manufactured and
meets regulatory requirements.
z Ensure documentation developed is adequate for its
intended purpose or requirement
z Make documents accessible to those who need them
z Ensure control of the accuracy and usage of current
versions of documents
z Maintain records of document changes
z management reviews
z non-conformities
Records (20%)
CAPA (50%)
PAPC (30%)
Non-QSIT Inspections
February 03 Alquest – Linda Alexander
Top Ten FDA 483 Items
Records (10%)
CAPA (30%)
PAPC (20%)
Mgmt (40%)
QSIT Inspections
February 03 Alquest – Linda Alexander
Confirm that quality audit
Verify existence of quality
procedures ensure that
policy, management review Confirm that management audits and reaudits of
and quality audit review procedures ensure deficient matters are
procedures. that executive management conducted.
reviews the suitability and
effectiveness with
Confirm implementation of
sufficient frequency Suspend inspection of
quality policy and
objectives. Management Controls -
Return to Management
Confirm that Management Controls Subsystem after
Confirm establishment of completing inspection of
Rep has been appointed?
org structure. other subsystems.
Does this person have
Does it have provisions for:
authority over and
- responsibility and
responsibility for:
authority?
- ensuring QS is effectively
- resources? Evaluate whether
established and
maintained? management with
- reporting on the executive responsibility
performance of the QS to ensures that an adequate
Management management with and effect QS has been
executive responsibility? established.
Controls
February 03 Alquest – Linda Alexander
For a selected design
Confirm that risk
project, confirm that
Confirm that device analysis was performed
procedures have been
defined and documented software was validated?
Confirm that design
Determine if any
Review the design plan changes were controlled
unresolved discrepancies
and assess the firm’s - including validation or
remain from design
conduct of risk analysis verification, where
validation
appropriate
Confirm that the design
Confirm that validation
inputs were established Confirm that design
demonstrated the
approved design met reviews were conducted
Confirm that design user needs and intended
outputs essential to the uses - and that activities
proper function of the Confirm that design was
were conducted on
device were identified correctly transferred to
production devices or
production
equivalent
Confirm that acceptance
criteria were established Confirm that verification Design
prior to test activities demonstrated that
outputs met inputs Controls
February 03 Alquest – Linda Alexander
Confirm that procedures
have been defined and Confirm that if process
documented cannot be fully verified,
it was validated
Confirm that if process
is software controlled,
Select a process and the software was
Confirm that:
confirm that process is validated
-nonconformances were
controlled and monitored handled appropriately
- equipment was
adjusted, calibrated and Confirm that personnel
maintained are qualified or trained
Confirm that process is to implement processes
-process was adequately
operating within
validated
specified limits
- per review of DHR or
other records
Production and
Process Controls
February 03 Alquest – Linda Alexander
Confirm that procedures Confirm that failure
have been defined and investigation procedures Confirm that appropriate
documented are followed action has been taken for
-is investigation level identified problems
commensurate with risk?
Confirm that quality data
- is investigation Confirm that action
sources have been
conducted to root cause? taken is:
identified and analyzed
- is product controlled to - effective
to identify existing
prevent distribution until - verified or validated
product and quality
resolution? prior to implementation
problems that require
corrective action - not detrimental to the
Confirm that data finished device
received by the CAPA - implemented and
Confirm that sources of
system are complete, documented
product and quality
information that may accurate and timely
show unfavorable trends -appropriate statistical Confirm that information
have been identified and methods used? has been properly
analyzed to identify - results compared across disseminated, including
issues that may require different data sources reports at management
preventive action review
February 03 Alquest – Linda Alexander
CAPA Controls
Audit Conduct
z Assign escort for Inspector(s)
– Typically QA personnel (Quality Management Rep)
– Capture questions, comments from Inspector and any
documents reviewed
– Intervene/clarify for “auditee”
z Seek department head for initial questions
z Prepare and coach department heads to
understand audit process
– Be truthful, but not volunteering
– Convince FDA that operation meets QS requirements
February 03 Alquest – Linda Alexander
At the Conclusion of the
Inspection ...
“Evaluate whether management with
executive responsibility ensures that
an adequate and effective quality
system has been established and
maintained.”
Develop
Improve/
Innovate
Monitor Manufacture
Distribute
February 03 Alquest – Linda Alexander
Quality System Regulation
z Develop a system that is appropriate for YOU
– Lots of flexibility in requirements for how the
system can be configured
– Don’t be afraid to make changes if something is
not working
z Can’t implement the changes until the documentation
is done
z Most of these requirements make good
business sense - use it to your advantage!
February 03 Alquest – Linda Alexander
Who Should Care?
z FDA expects that a company producing
product for use in humans is meeting the
Quality System Regulation
– Non-compliance may result in Warning Letter,
negative publicity, submission hold, civil penalties
z FDA holds Company Management responsible
for function of the Quality System
z FDA specifically meets with the “most
responsible” person in the company to discuss
the commitment to quality
February 03 Alquest – Linda Alexander
Questions??